From: Early stage chronic kidney disease: a paradigm for diffuse fibrosis and clinical progression
 | CKD (n = 30) | Controls(n = 30) |
---|---|---|
LVEDVi (ml/m2) | 70 (14) | 64 (13) |
LVESVi (ml/m2) | 21 (7) | 19 (7) |
LV mass index (g/m2) | 63 (14) | 58 (13) |
LVEF (%) | 71 (6) | 73 (6) |
MAPSE (mm) | 13 (2) | 17 (3)* |
LA volume index (ml/m2) | 45 (12) | 33 (10)* |
Peak longitudinal systolic strain (%) | 14.8 (2.0) | 17.1 (2.0)* |
Peak longitudinal systolic strain rate (s-1) | 0.71 (0.35) | 0.91 (0.23) |
Early longitudinal diastolic strain rate (s-1) | 0.50 (0.17) | 0.67 (0.24)* |
Aortic distensibility (mmHg-1) | 2.20 (1.56) | 3.7 (1.67)* |